Enliven Therapeutics
ELVN
#5641
Rank
C$1.65 B
Marketcap
C$27.85
Share price
3.49%
Change (1 day)
-17.41%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.53 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is C$0.53 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2024-12-31N/A-100%
2023-12-31C$0.44 M1.38%
2022-12-31C$0.43 M116.3%
2021-12-31C$0.2 M51.35%
2020-12-31C$0.13 M